First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection
Clinical trial NCT04297917 · COMPLETED
Trial details
- NCT number
- NCT04297917
- Sponsor
- Barinthus Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-10
- Primary completion
- 2022-05-23
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.